Analyst Ratings (USA)
American analyst sentiment on November 10th is mixed but cautiously optimistic, with positive recommendations concentrated in technology, artificial intelligence infrastructure, biotechnology, industrials, and select financial companies. New coverage and upgrades reflect confidence in long-term earnings growth and structural investment opportunities, particularly in cloud computing, critical minerals, and infrastructure. However, widespread price-target reductions and downgrades across software, consumer discretionary, gaming, and emerging technology companies highlight increasing concerns about valuations, profitability, and slowing growth expectations.
Updates (322)
AAON Inc. (AAON) — Oppenheimer maintains its Outperform rating and lowers its price target to $105.00 from $115.00.
AAON Inc. (AAON) — Robert W. Baird maintains its Outperform rating and lowers its price target to $104.00 from $110.00.
AbCellera Biologics (ABCL) — Stifel Nicolaus maintains its Buy rating and raises its price target to $14.00 from $9.00.
Abercrombie & Fitch (ANF) — The Goldman Sachs Group reiterates its Buy rating with a price target of $180.00.
Academy Sports + Outdoors (ASO) — Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $89.00.
Academy Sports + Outdoors (ASO) — Loop Capital downgrades the stock from Buy to Hold with a price target of $69.00.
Adaptive Biotechnologies (ADPT) — Guggenheim maintains its Buy rating and raises its price target to $34.00 from $32.00.
AerSale (ASLE) — Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $6.00 from $7.00.
Affiliated Managers Group (AMG) — TD Cowen maintains its Buy rating and raises its price target to $583.00 from $523.00.
Allstate (ALL) — Keefe, Bruyette & Woods maintains its Underperform rating and raises its price target to $241.00 from $232.00.
Allstate (ALL) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $260.00 from $240.00.
Allstate (ALL) — UBS Group maintains its Neutral rating and raises its price target to $283.00 from $275.00.
Alvotech (ALVO) — Jefferies initiates coverage with a Buy rating with a price target of $9.00.
Amcor (AMCR) — Citigroup maintains its Buy rating and lowers its price target to $50.00 from $52.00.
Amer Sports (AS) — Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $46.00.
American Axle & Manufacturing (DCH) — Stifel Nicolaus maintains its Hold rating and lowers its price target to $5.00 from $6.00.
American Healthcare REIT (AHR) — Citigroup maintains its Buy rating and raises its price target to $67.00 from $65.00.
American Healthcare REIT (AHR) — Raymond James Financial reiterates its Strong-Buy rating with a price target of $72.00.
American Healthcare REIT (AHR) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $66.00 from $61.00.
American International Group (AIG) — UBS Group maintains its Buy rating and raises its price target to $103.00 from $100.00.
American Public Education (APEI) — B. Riley Financial maintains its Buy rating and raises its price target to $68.00 from $65.00.
Amylyx Pharmaceuticals (AMLX) — Mizuho maintains its Outperform rating and raises its price target to $39.00 from $38.00.
Angi (ANGI) — UBS Group maintains its Neutral rating and raises its price target to $9.00 from $5.00.
Antero Midstream (AM) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $24.00 from $26.00.
Apple Hospitality REIT (APLE) — Cantor Fitzgerald maintains its Overweight rating and raises its price target to $22.00 from $18.00.
Archer Aviation (ACHR) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $10.00 from $11.00.
Archer Aviation (ACHR) — Needham & Company LLC maintains its Buy rating and lowers its price target to $7.00 from $9.00.
Arcos Dorados (ARCO) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $10.00 from $10.50.
Arhaus (ARHS) — Guggenheim maintains its Buy rating and raises its price target to $17.00 from $12.00.
ArriVent BioPharma (AVBP) — Truist Financial maintains its Buy rating and raises its price target to $24.00 from $21.00.
Assurant (AIZ) — UBS Group maintains its Buy rating and raises its price target to $377.00 from $331.00.
AST SpaceMobile (ASTS) — B. Riley Financial maintains its Neutral rating and lowers its price target to $48.00 from $65.00.
AST SpaceMobile (ASTS) — Bank of America reiterates its Neutral rating.
AST SpaceMobile (ASTS) — Citigroup reiterates its Positive rating.
AST SpaceMobile (ASTS) — UBS Group maintains its Neutral rating and lowers its price target to $43.00 from $78.00.
Atlanticus (ATLC) — Citigroup reiterates its Market Outperform rating.
Atlanticus (ATLC) — Citizens Jmp maintains its Market Outperform rating and raises its price target to $117.00 from $110.00.
Aura Biosciences (AURA) — Citigroup reiterates its Market Outperform rating.
AvePoint (AVPT) — Morgan Stanley downgrades the stock from Overweight to Equal Weight.
Babcock (BW) — Needham & Company LLC maintains its Buy rating and lowers its price target to $15.00 from $20.00.
Barrick Mining (B) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $53.00 from $55.00.
Becton, Dickinson and Company (BDX) — Barclays maintains its Underweight rating and raises its price target to $195.00 from $165.00.
Better Home & Finance (BETR) — B. Riley Financial maintains its Buy rating and lowers its price target to $23.00 from $26.00.
Better Home & Finance (BETR) — Needham & Company LLC reiterates its Buy rating with a price target of $22.00.
Bicara Therapeutics (BCAX) — BTIG Research maintains its Buy rating and lowers its price target to $37.00 from $39.00.
Bicara Therapeutics (BCAX) — Citigroup reiterates its Market Outperform rating.
Bicara Therapeutics (BCAX) — Morgan Stanley maintains its Overweight rating and lowers its price target to $30.00 from $41.00.
Bicara Therapeutics (BCAX) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $43.00 from $45.00.
Billiontoone (BLLN) — Piper Sandler maintains its Overweight rating and lowers its price target to $130.00 from $140.00.
Black Diamond Therapeutics (BDTX) — Raymond James Financial reiterates its Outperform rating.
BlackSky Technology (BKSY) — Jefferies Financial Group reiterates its Hold rating with a price target of $27.00.
Blackstone Secured Lending Fund (BXSL) — B. Riley Financial maintains its Neutral rating and lowers its price target to $22.50 from $23.50.
Booz Allen Hamilton (BAH) — Citigroup maintains its Neutral rating and raises its price target to $94.00 from $88.00.
British American Tobacco (BTI) — JP Morgan resumes coverage with an Overweight rating.
British American Tobacco (BTI) — JPMorgan Chase & Co. initiates coverage with an Overweight rating.
Brookdale Senior Living (BKD) — Barclays maintains its Overweight rating and lowers its price target to $14.00 from $17.00.
Brookfield (BN) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $65.00 from $56.00.
BTGO (BTGO) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $12.00 from $15.00.
BTGO (BTGO) — Mizuho maintains its Outperform rating and lowers its price target to $9.00 from $11.00.
BTGO (BTGO) — Rosenblatt Securities maintains its Buy rating and lowers its price target to $9.00 from $10.00.
BTGO (BTGO) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $9.00 from $11.00.
Burlington Stores (BURL) — Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $270.00.
Cabot (CBT) — JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $68.00 from $78.00.
Camden Property Trust (CPT) — UBS Group maintains its Neutral rating and raises its price target to $107.00 from $101.00.
Cardinal Health (CAH) — JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $286.00 from $260.00.
CareTrust REIT (CTRE) — Raymond James Financial reiterates its Outperform rating with a price target of $41.00.
Caris Life Sciences (CAI) — Piper Sandler maintains its Neutral rating and raises its price target to $25.00 from $22.00.
Carlyle Group (CG) — The Goldman Sachs Group maintains its Buy rating and lowers its price target to $58.00 from $66.00.
Carlyle Group (CG) — UBS downgrades the stock from Buy to Neutral and lowers its price target to $47.00 from $60.00.
Carvana (CVNA) — Argus sets a price target of $100.00.
Celanese (CE) — UBS Group maintains its Neutral rating and raises its price target to $58.00 from $53.00.
Cencora (COR) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $413.00 from $390.00.
Centerspace (CSR) — UBS Group maintains its Neutral rating and raises its price target to $68.00 from $65.00.
Ceva (CEVA) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $35.00 from $45.00.
Ceva (CEVA) — Oppenheimer maintains its Outperform rating and lowers its price target to $35.00 from $38.00.
Ceva (CEVA) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $40.00 from $50.00.
Ceva (CEVA) — UBS Group maintains its Buy rating and lowers its price target to $35.00 from $40.00.
Charter Communications (CHTR) — Citigroup maintains its Buy rating and raises its price target to $150.00 from $140.00.
Chord Energy (CHRD) — UBS Group maintains its Buy rating and raises its price target to $198.00 from $197.00.
Cipher Mining (CIFR) — Jefferies Financial Group maintains its Buy rating and lowers its price target to $10.00 from $12.00.
City (CHCO) — Jefferies Financial Group initiates coverage with a Buy rating.
City Therapeutics (CTY) — Jefferies initiates coverage with a Buy rating with a price target of $32.00.
City Therapeutics (CTY) — Oppenheimer initiates coverage with an Outperform rating with a price target of $46.00.
City Therapeutics (CTY) — Stifel initiates coverage with a Buy rating with a price target of $34.00.
City Therapeutics (CTY) — The Goldman Sachs Group initiates coverage with an Early-Stage Biotech rating.
Clarus (CLAR) — B. Riley Financial maintains its Buy rating and raises its price target to $6.00 from $4.50.
Cloudflare (NET) — DZ Bank upgrades the stock from Sell to Buy with a price target of $300.00.
CNH Industrial (CNH) — Barclays maintains its Overweight rating and raises its price target to $15.00 from $14.00.
CNH Industrial (CNH) — Citigroup maintains its Buy rating and raises its price target to $15.00 from $13.00.
CNH Industrial (CNH) — JPMorgan Chase & Co. maintains its Underweight rating and raises its price target to $12.00 from $11.00.
CNH Industrial (CNH) — Raymond James Financial reiterates its Outperform rating with a price target of $15.00.
CNH Industrial (CNH) — Robert W. Baird maintains its Outperform rating and raises its price target to $16.00 from $15.00.
CNH Industrial (CNH) — Sanford C. Bernstein reiterates its Market Perform rating with a price target of $12.00.
CNH Industrial (CNH) — Truist Financial maintains its Buy rating and lowers its price target to $16.00 from $17.00.
Comfort Systems (FIX) — JP Morgan initiates coverage with an Overweight rating with a price target of $1,700.00.
Comfort Systems USA (FIX) — JPMorgan Chase & Co. initiates coverage with an Overweight rating with a price target of $1,700.00.
Compass Therapeutics (CMPX) — Wedbush maintains its Neutral rating and lowers its price target to $0.90 from $1.00.
Cooper-Standard (CPS) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $29.00 from $32.00.
Core Scientific (CORZ) — Citigroup reiterates its Market Outperform rating.
CorMedix (CRMD) — Citigroup reiterates its Market Outperform rating.
CorMedix (CRMD) — Needham & Company LLC maintains its Buy rating and raises its price target to $14.00 from $12.00.
CorMedix (CRMD) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $15.00 from $14.00.
CorMedix (CRMD) — UBS Group sets a price target of $19.00.
Costco (COST) — Freedom Broker downgrades the stock from Buy to Hold and raises its price target to $1,050.00 from $1,010.00.
CRISPR Therapeutics (CRSP) — Piper Sandler reiterates its Overweight rating with a price target of $110.00.
Criteo (CRTO) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $20.00 from $25.00.
Csquare (CSQR) — Bank of America reiterates its Buy rating.
Csquare (CSQR) — Sanford C. Bernstein reiterates its Outperform rating with a price target of $28.00.
Csquare (CSQR) — TD Cowen maintains its Buy rating and raises its price target to $30.00 from $28.00.
Cummins (CMI) — UBS Group maintains its Buy rating and lowers its price target to $675.00 from $741.00.
Curtiss-Wright (CW) — Citigroup maintains its Neutral rating and lowers its price target to $505.00 from $622.00.
Cytek Biosciences (CTKB) — Stephens maintains its Overweight rating and raises its price target to $7.00 from $6.00.
Deckers Outdoor (DECK) — Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $89.00.
Definium Therapeutics (DFTX) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $70.00 from $66.00.
Delcath Systems (DCTH) — HC Wainwright maintains its Buy rating and raises its price target to $36.00 from $32.00.
Devon Energy (DVN) — UBS Group maintains its Buy rating and lowers its price target to $62.00 from $65.00.
Dick’s Sporting Goods (DKS) — Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $146.00.
Docebo (DCBO) — Scotiabank maintains its Sector Outperform rating and raises its price target to $35.00 from $25.00.
DocGo (DCGO) — Needham & Company LLC maintains its Buy rating and lowers its price target to $1.00.
DraftKings (DKNG) — Berenberg downgrades the stock from Buy to Hold with a price target of $20.00.
DraftKings (DKNG) — Citigroup maintains its Buy rating and lowers its price target to $22.00 from $28.00.
DraftKings (DKNG) — Wells Fargo downgrades the stock from Overweight to Equal Weight with a price target of $21.00.
e.l.f. Beauty (ELF) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $125.00 from $103.00.
East West Banc (EWBC) — Hovde Group initiates coverage with an Outperform rating with a price target of $153.00.
Edgewell Personal Care (EPC) — Royal Bank Of Canada reiterates its Outperform rating with a price target of $35.00.
Electra Battery Materials (ELBM) — HC Wainwright reiterates its Buy rating with a price target of $2.00.
EMCOR Group (EME) — JP Morgan initiates coverage with a Neutral rating with a price target of $700.00.
EMCOR Group (EME) — JPMorgan Chase & Co. initiates coverage with a Neutral rating with a price target of $700.00.
Endeavour Silver (EXK) — HC Wainwright maintains its Buy rating and lowers its price target to $16.75 from $17.00.
EOG Resources (EOG) — Susquehanna maintains its Positive rating and raises its price target to $196.00 from $187.00.
Essex Property Trust (ESS) — Truist Financial maintains its Hold rating and raises its price target to $288.00 from $286.00.
Essex Property Trust (ESS) — UBS Group maintains its Neutral rating and raises its price target to $286.00 from $275.00.
Estee Lauder Companies (EL) — Citigroup maintains its Buy rating and raises its price target to $132.00 from $121.00.
Eton Pharmaceuticals (ETON) — B. Riley Financial maintains its Buy rating and raises its price target to $81.00 from $70.00.
Everus Construction Group (ECG) — Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $123.00 from $152.00.
Everus Construction Group (ECG) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $139.00 from $172.00.
EVgo Inc. (EVGO) — RBC Capital Mkts downgrades the stock from Outperform to Sector Perform and raises its price target to $2.00 from $1.75.
EVgo Inc. (EVGO) — Roth Capital downgrades the stock from Buy to Neutral with a price target of $2.00.
Excelerate Energy (EE) — Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $40.00 from $38.00.
Ferguson (FERG) — Barclays maintains its Overweight rating and raises its price target to $314.00 from $313.00.
Ferguson (FERG) — Oppenheimer maintains its Outperform rating and raises its price target to $296.00 from $288.00.
Ferguson (FERG) — Robert W. Baird maintains its Outperform rating and raises its price target to $300.00 from $288.00.
Ferguson (FERG) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $288.00 from $286.00.
Ferguson (FERG) — Sanford C. Bernstein reiterates its Outperform rating.
Ferguson (FERG) — UBS Group maintains its Neutral rating and raises its price target to $270.00 from $256.00.
Fervo Energy (FRVO) — Robert W. Baird maintains its Outperform rating and lowers its price target to $20.00 from $26.00.
Fidelity National Financial (FNF) — Keefe, Bruyette & Woods maintains its Outperform rating and raises its price target to $55.00 from $53.00.
FIGS, Inc. (FIGS) — Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $25.00.
First Advantage (FA) — Citigroup maintains its Neutral rating and raises its price target to $25.00 from $22.00.
First Solar (FSLR) — UBS Group maintains its Buy rating and lowers its price target to $295.00 from $330.00.
Fiserv (FISV) — Truist Financial maintains its Hold rating and raises its price target to $65.00 from $51.00.
Flowco (FLOC) — Citigroup maintains its Neutral rating and lowers its price target to $25.00 from $27.00.
Flutter Entertainment (FLUT) — Cfra downgrades the stock to Buy ? Hold with a price target of $94.00.
Forward Air (FWRD) — Stifel Nicolaus maintains its Buy rating and raises its price target to $28.00 from $27.00.
Fulgent Genetics (FLGT) — Piper Sandler maintains its Neutral rating and raises its price target to $25.00 from $19.00.
GCM Grosvenor (GCMG) — JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $14.50 from $13.00.
GCM Grosvenor (GCMG) — Piper Sandler maintains its Overweight rating and raises its price target to $15.00 from $14.50.
GE Vernova (GEV) — Glj Research reiterates its Sell rating with a price target of $540.00.
GeneDx (WGS) — BTIG Research maintains its Buy rating and lowers its price target to $85.00 from $90.00.
Gilat Satellite (GILT) — William Blair downgrades the stock from Outperform to Market Perform.
Global Payments (GPN) — Mizuho maintains its Outperform rating and sets a price target of $115.00 from $110.00.
Goldman Sachs BDC (GSBD) — Truist Financial maintains its Hold rating and lowers its price target to $9.00 from $10.00.
Goosehead Insurance (GSHD) — Piper Sandler maintains its Neutral rating and raises its price target to $56.00 from $48.00.
GRAIL (GRAL) — Piper Sandler maintains its Neutral rating and raises its price target to $130.00 from $74.00.
Greystone Housing Impact Investors (GHI) — JonesTrading maintains its Buy rating and lowers its price target to $6.00 from $7.00.
Guardant Health (GH) — Piper Sandler maintains its Overweight rating and lowers its price target to $190.00 from $193.00.
Gulfport Energy (GPOR) — UBS Group maintains its Buy rating and lowers its price target to $217.00 from $218.00.
H&R Block (HRB) — The Goldman Sachs Group maintains its Sell rating and raises its price target to $40.00 from $36.00.
The Hain Celestial Group (HAIN) — Barclays maintains its Underweight rating and lowers its price target to $0.10 from $0.30.
Harley-Davidson (HOG) — Argus sets a price target of $38.00.
Hims & Hers Health (HIMS) — Jefferies Financial Group maintains its Hold rating and lowers its price target to $24.00 from $31.00.
Hims & Hers Health (HIMS) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $25.00 from $28.00.
Hims & Hers Health (HIMS) — Needham & Company LLC maintains its Buy rating and lowers its price target to $32.00 from $42.00.
HIVE Digital Technologies (HIVE) — Chardan Capital maintains its Buy rating and lowers its price target to $7.00 from $7.50.
Home Depot (HD) — Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $357.00 from $344.00.
Horizon Technology Finance (HRZN) — B. Riley Financial maintains its Neutral rating and lowers its price target to $4.50 from $5.00.
Horizon Technology Finance (HRZN) — UBS Group maintains its Neutral rating and lowers its price target to $3.75 from $4.50.
Host Hotels & Resorts (HST) — Cantor Fitzgerald maintains its Neutral rating and raises its price target to $27.00 from $24.00.
Humacyte (HUMA) — BTIG Research reiterates its Buy rating with a price target of $2.00.
Humana (HUM) — JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $484.00 from $393.00.
Huntington Ingalls Industries (HII) — Citigroup maintains its Buy rating and lowers its price target to $352.00 from $379.00.
Hut 8 (HUT) — Jefferies Financial Group maintains its Buy rating and lowers its price target to $81.00 from $90.00.
Iambic Therapeutics (IAM) — Jefferies initiates coverage with a Buy rating with a price target of $35.00.
IBEX (IBEX) — Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $45.00 from $40.00.
Immunocore (IMCR) — HC Wainwright maintains its Buy rating and lowers its price target to $80.00 from $100.00.
Immunome (IMNM) — Piper Sandler maintains its Overweight rating and lowers its price target to $30.00 from $33.00.
Immunome (IMNM) — Stifel Nicolaus maintains its Hold rating and lowers its price target to $23.00 from $24.00.
Immunovant (IMVT) — Truist Financial maintains its Hold rating and raises its price target to $33.00 from $30.00.
Immunovant (IMVT) — Wells Fargo & Company maintains its Overweight rating and raises its price target to $47.00 from $45.00.
Independence Realty Trust (IRT) — UBS Group maintains its Buy rating and raises its price target to $18.00 from $17.00.
Ionis Pharmaceuticals (IONS) — Bank of America reiterates its Buy rating.
Ionis Pharmaceuticals (IONS) — HC Wainwright maintains its Buy rating and lowers its price target to $70.00 from $100.00.
Ionis Pharmaceuticals (IONS) — Morgan Stanley maintains its Overweight rating and lowers its price target to $75.00 from $104.00.
Ionis Pharmaceuticals (IONS) — Oppenheimer maintains its Outperform rating and lowers its price target to $70.00 from $85.00.
Ionis Pharmaceuticals (IONS) — Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $60.00 from $85.00.
Ionis Pharmaceuticals (IONS) — TD Cowen maintains its Buy rating and lowers its price target to $53.00 from $84.00.
Ionis Pharmaceuticals (IONS) — The Goldman Sachs Group maintains its Neutral rating and lowers its price target to $41.00 from $58.00.
Ionis Pharmaceuticals (IONS) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $80.00 from $95.00.
JetBlue Airways (JBLU) — UBS Group maintains its Neutral rating and raises its price target to $4.00 from $3.50.
JinkoSolar (JKS) — Glj Research maintains its Sell rating and lowers its price target to $5.27 from $12.08.
Kinetik (KNTK) — Morgan Stanley maintains its Overweight rating and lowers its price target to $64.00 from $67.00.
KKR & Co. Inc. (KKR) — Morgan Stanley maintains its Overweight rating and raises its price target to $140.00 from $138.00.
KKR & Co. Inc. (KKR) — Oppenheimer maintains its Outperform rating and lowers its price target to $156.00 from $163.00.
KKR & Co. Inc. (KKR) — Royal Bank Of Canada reiterates its Outperform rating with a price target of $134.00.
KKR & Co. Inc. (KKR) — Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $105.00 from $97.00.
Kodiak Gas Services (KGS) — Jefferies Financial Group maintains its Buy rating and lowers its price target to $52.00 from $53.00.
Kodiak Gas Services (KGS) — Mizuho maintains its Outperform rating and lowers its price target to $68.00 from $72.00.
Kodiak Gas Services (KGS) — Raymond James Financial reiterates its Outperform rating with a price target of $70.00.
Kodiak Gas Services (KGS) — Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $78.00 from $82.00.
Kodiak Gas Services (KGS) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $90.00 from $92.00.
Kratos Defense & Security Solutions (KTOS) — Barclays maintains its Overweight rating and lowers its price target to $80.00 from $90.00.
Larimar Therapeutics (LRMR) — Wedbush reiterates its Outperform rating.
LegalZoom.com (LZ) — Citigroup maintains its Neutral rating and lowers its price target to $5.50 from $6.00.
Leidos (LDOS) — Citigroup maintains its Buy rating and raises its price target to $163.00 from $141.00.
LENSAR (LNSR) — BTIG Research maintains its Buy rating and lowers its price target to $9.00 from $10.00.
Liberty Media Corporation – Liberty Formula One Series A (FWONA) — TD Cowen maintains its Buy rating and raises its price target to $113.00 from $107.00.
Liberty Media Corporation – Liberty Formula One Series C (FWONK) — TD Cowen maintains its Buy rating and raises its price target to $125.00 from $118.00.
Lincoln Educational Services (LINC) — B. Riley Financial maintains its Buy rating and lowers its price target to $50.00 from $52.00.
Lincoln Educational Services (LINC) — Rosenblatt Securities maintains its Buy rating and lowers its price target to $40.00 from $50.00.
Liquidia (LQDA) — BTIG Research maintains its Buy rating and raises its price target to $87.00 from $70.00.
Liquidia (LQDA) — Jefferies Financial Group maintains its Buy rating and raises its price target to $62.00 from $55.00.
Live Nation Entertainment (LYV) — Oppenheimer maintains its Outperform rating and raises its price target to $215.00 from $210.00.
loanDepot (LDI) — Bank of America reiterates its Underperform rating.
Lowe’s Companies (LOW) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $270.00 from $254.00.
LPL Financial (LPLA) — Morgan Stanley maintains its Overweight rating and raises its price target to $399.00 from $393.00.
LTC Properties (LTC) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $53.00 from $52.00.
Lucid Group (LCID) — Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $6.00 from $8.00.
Lucid Group (LCID) — Needham & Company LLC reiterates its Hold rating.
Lucid Group (LCID) — Robert W. Baird maintains its Neutral rating and lowers its price target to $5.00 from $6.00.
Lucid Group (LCID) — TD Cowen maintains its Hold rating and lowers its price target to $4.00 from $7.00.
lululemon athletica (LULU) — Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $121.00.
Lumentum (LITE) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $700.00 from $635.00.
Lumentum (LITE) — UBS Group maintains its Neutral rating and lowers its price target to $686.00 from $960.00.
Magnolia Oil & Gas (MGY) — Citigroup maintains its Neutral rating and lowers its price target to $26.00 from $27.00.
Magnolia Oil & Gas (MGY) — Gerdes Energy Research upgrades the stock to Neutral ? Buy with a price target of $29.00.
Main Street Capital (MAIN) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $59.00 from $60.00.
MARA (MARA) — Compass Point reiterates its Buy rating with a price target of $20.00.
MARA (MARA) — Guggenheim reiterates its Neutral rating.
MARA (MARA) — Rosenblatt Securities maintains its Buy rating and lowers its price target to $11.00 from $15.00.
Martin Marietta Materials (MLM) — B. Riley Financial maintains its Buy rating and lowers its price target to $615.00 from $700.00.
Mastercard (MA) — Citigroup maintains its Buy rating and raises its price target to $800.00 from $675.00.
Maze Therapeutics (MAZE) — Wedbush maintains its Outperform rating and raises its price target to $49.00 from $48.00.
McEwen (MUX) — HC Wainwright maintains its Buy rating and lowers its price target to $27.00 from $28.00.
McKesson (MCK) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $1,255.00 from $1,042.00.
MDA Space (MDA) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $44.00 from $50.00.
Mereo BioPharma Group (MREO) — BTIG Research reiterates its Buy rating with a price target of $1.00.
Mesa Laboratories (MLAB) — Jefferies Financial Group maintains its Buy rating and raises its price target to $150.00 from $125.00.
Microsoft (MSFT) — Royal Bank Of Canada reiterates its Outperform rating.
Microvast (MVST) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $2.00.
Mid-America Apartment Communities (MAA) — UBS Group maintains its Neutral rating and raises its price target to $128.00 from $123.00.
MidCap Financial Investment (MFIC) — Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $11.00 from $10.00.
monday.com (MNDY) — Bank of America reiterates its Neutral rating.
monday.com (MNDY) — Barclays maintains its Equal Weight rating and lowers its price target to $91.00 from $100.00.
monday.com (MNDY) — BTIG Research maintains its Buy rating and lowers its price target to $100.00 from $105.00.
monday.com (MNDY) — Citigroup maintains its Buy rating and lowers its price target to $127.00 from $132.00.
monday.com (MNDY) — Jefferies Financial Group maintains its Hold rating and lowers its price target to $90.00 from $95.00.
monday.com (MNDY) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $84.00 from $87.00.
monday.com (MNDY) — Morgan Stanley maintains its Overweight rating and lowers its price target to $109.00 from $115.00.
monday.com (MNDY) — TD Cowen maintains its Hold rating and lowers its price target to $95.00 from $105.00.
monday.com (MNDY) — UBS Group maintains its Neutral rating and lowers its price target to $90.00 from $95.00.
monday.com (MNDY) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $100.00 from $120.00.
MongoDB (MDB) — BTIG Research initiates coverage with a Buy rating with a price target of $417.00.
Morgan Stanley Direct Lending (MSDL) — UBS upgrades the stock from Neutral to Buy and lowers its price target to $14.50 from $15.50.
Motorcar Parts of America (MPAA) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $18.00 from $20.00.
MP Materials (MP) — Freedom Broker upgrades the stock from Hold to Buy with a price target of $51.00.
Mplx (MPLX) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $60.00 from $64.00.
National Energy Services Reunited (NESR) — Barclays maintains its Overweight rating and lowers its price target to $37.00 from $41.00.
National Energy Services Reunited (NESR) — UBS Group maintains its Buy rating and lowers its price target to $40.00 from $46.00.
NerdWallet (NRDS) — Citigroup maintains its Neutral rating and lowers its price target to $8.50 from $11.00.
Nerdy (NRDY) — Needham & Company LLC maintains its Buy rating and raises its price target to $8.00 from $2.00.
Neurogene (NGNE) — HC Wainwright maintains its Buy rating and lowers its price target to $60.00 from $65.00.
NexPoint Real Estate Finance (NREF) — Keefe, Bruyette & Woods maintains its Market Perform rating and lowers its price target to $14.00 from $15.00.
Nextpower (NXT) — Citigroup maintains its Buy rating and raises its price target to $126.00 from $119.00.
NIKE (NKE) — Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $38.00.
NMI (NMIH) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $46.00 from $45.00.
NNN REIT (NNN) — Truist Financial maintains its Hold rating and raises its price target to $46.00 from $45.00.
NovoCure (NVCR) — LADENBURG THALM/SH SH maintains its Buy rating and raises its price target to $31.00 from $27.00.
NovoCure (NVCR) — Wedbush maintains its Neutral rating and lowers its price target to $19.00 from $20.00.
NRG Energy (NRG) — Raymond James Financial maintains its Strong-Buy rating and sets a price target of $150.00.
NVIDIA (NVDA) — Citigroup maintains its Buy rating and lowers its price target to $285.00 from $315.00.
NVIDIA (NVDA) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $300.00 from $315.00.
Ocular Therapeutix (OCUL) — HC Wainwright maintains its Buy rating and raises its price target to $28.00 from $25.00.
On (ONON) — Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $46.00.
ONEOK (OKE) — Barclays resumes coverage with an Equal Weight rating with a price target of $94.00.
Onto Innovation (ONTO) — Jefferies Financial Group maintains its Buy rating and lowers its price target to $350.00 from $400.00.
Onto Innovation (ONTO) — Morgan Stanley maintains its Overweight rating and lowers its price target to $325.00 from $360.00.
Onto Innovation (ONTO) — Needham & Company LLC maintains its Buy rating and lowers its price target to $285.00 from $360.00.
Onto Innovation (ONTO) — Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $350.00 from $400.00.
Onto Innovation (ONTO) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $305.00 from $350.00.
Oracle (ORCL) — KeyCorp reiterates its Overweight rating.
Orion (OEC) — JPMorgan Chase & Co. upgrades the stock to Underweight ? Neutral.
Orion Engineered Carbons (OEC) — JP Morgan upgrades the stock from Underweight to Neutral.
Orthofix Medical (OFIX) — TD Cowen reiterates its Hold rating.
Oruka Therapeutics (ORKA) — BTIG Research reiterates its Buy rating with a price target of $151.00.
Palomar (PLMR) — Keefe, Bruyette & Woods maintains its Outperform rating and raises its price target to $172.00 from $161.00.
Park Hotels & Resorts (PK) — Cantor Fitzgerald maintains its Neutral rating and raises its price target to $17.00 from $15.00.
Parsons (PSN) — Citigroup maintains its Buy rating and raises its price target to $63.00 from $53.00.
Patterson-UTI Energy (PTEN) — Citigroup maintains its Neutral rating and lowers its price target to $11.00 from $12.50.
Peabody Energy (BTU) — Jefferies downgrades the stock from Buy to Hold and lowers its price target to $18.00 from $30.00.
Pebblebrook Hotel Trust (PEB) — Cantor Fitzgerald maintains its Neutral rating and raises its price target to $23.00 from $19.00.
PepGen (PEPG) — BofA Securities upgrades the stock from Underperform to Neutral with a price target of $6.00.
Philip Morris International (PM) — JP Morgan resumes coverage with a Neutral rating with a price target of $200.00.
Philip Morris International (PM) — JPMorgan Chase & Co. initiates coverage with a Neutral rating with a price target of $200.00.
Planet Fitness (PLNT) — Jefferies Financial Group reiterates its Buy rating.
Plug Power (PLUG) — Craig Hallum reiterates its Buy rating.
Plug Power (PLUG) — HC Wainwright reiterates its Buy rating with a price target of $7.00.
Plug Power (PLUG) — KeyCorp sets a price target of $3.00.
Plug Power (PLUG) — Oppenheimer reiterates its Market Perform rating.
Plug Power (PLUG) — Royal Bank Of Canada reiterates its Sector Perform rating with a price target of $2.00.
Praxis Precision Medicines (PRAX) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $478.00 from $462.00.
Praxis Precision Medicines (PRAX) — Wedbush maintains its Underperform rating and raises its price target to $189.00 from $188.00.
Praxis Precision Medicines (PRAX) — Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $343.00 from $362.00.
Primo Brands (PRMB) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $27.00 from $26.00.
PubMatic (PUBM) — B. Riley Financial maintains its Buy rating and raises its price target to $24.00 from $21.00.
PubMatic (PUBM) — Rosenblatt Securities maintains its Buy rating and raises its price target to $25.00 from $23.00.
PubMatic (PUBM) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $22.00 from $20.00.
PubMatic (PUBM) — UBS Group reiterates its Buy rating.
Qualys (QLYS) — Jefferies Financial Group maintains its Hold rating and lowers its price target to $215.00 from $235.00.
Qualys (QLYS) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $215.00 from $241.00.
Qualys (QLYS) — Morgan Stanley maintains its Underweight rating and raises its price target to $140.00 from $130.00.
Qualys (QLYS) — Piper Sandler maintains its Neutral rating and raises its price target to $185.00 from $175.00.
Qualys (QLYS) — Robert W. Baird maintains its Neutral rating and raises its price target to $210.00 from $160.00.
Qualys (QLYS) — Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $197.00 from $180.00.
Qualys (QLYS) — UBS Group maintains its Neutral rating and raises its price target to $210.00 from $170.00.
Qualys (QLYS) — Wedbush maintains its Neutral rating and raises its price target to $185.00 from $175.00.
Quanterix (QTRX) — TD Cowen maintains its Hold rating and raises its price target to $4.00 from $3.50.
Quantum (QMCO) — Cantor Fitzgerald maintains its Overweight rating and raises its price target to $32.00 from $29.00.
Quantum Computing (QUBT) — Wedbush reiterates its Neutral rating.
Radian Group (RDN) — Keefe, Bruyette & Woods maintains its Outperform rating and lowers its price target to $43.00 from $44.00.
Radian Group (RDN) — Royal Bank Of Canada sets a price target of $43.00.
RadNet (RDNT) — KeyCorp maintains its Overweight rating and raises its price target to $95.00 from $92.00.
Ralph Lauren (RL) — Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $426.00.
RB Global (RBA) — Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $134.00 from $152.00.
Realty Income (O) — Truist Financial maintains its Hold rating and raises its price target to $63.00 from $60.00.
Reddit (RDDT) — Guggenheim maintains its Buy rating and lowers its price target to $140.00 from $170.00.
Remitly Global (RELY) — KeyCorp reiterates its Overweight rating.
Repay (RPAY) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $7.00 from $8.00.
Repay (RPAY) — UBS Group maintains its Neutral rating and raises its price target to $4.75 from $4.25.
Riot Platforms (RIOT) — Jefferies upgrades the stock from Hold to Buy with a price target of $28.00.
RLJ Lodging Trust (RLJ) — Oppenheimer maintains its Outperform rating and raises its price target to $15.00 from $13.00.
Rocket Lab (RKLB) — Barclays maintains its Overweight rating and lowers its price target to $82.00 from $85.00.
Rocket Lab (RKLB) — BTIG Research reiterates its Neutral rating.
Rocket Lab (RKLB) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $111.00 from $122.00.
Rocket Lab (RKLB) — KeyCorp reiterates its Overweight rating with a price target of $100.00.
Rocket Lab (RKLB) — Piper Sandler maintains its Neutral rating and lowers its price target to $58.00 from $83.00.
Roivant Sciences (ROIV) — HC Wainwright maintains its Buy rating and raises its price target to $48.00 from $47.00.
Roku (ROKU) — Wedbush maintains its Neutral rating.
Ross Stores (ROST) — Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $276.00.
RPM International (RPM) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $125.00 from $120.00.
Ryman Hospitality Properties (RHP) — Cantor Fitzgerald maintains its Overweight rating and raises its price target to $152.00 from $135.00.
Sally Beauty (SBH) — Raymond James Financial maintains its Outperform rating and sets a price target of $18.00.
SandRidge Energy (SD) — Freedom Broker upgrades the stock from Hold to Buy with a price target of $14.00.
Sanmina (SANM) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $230.00 from $270.00.
Sarepta Therapeutics (SRPT) — Deutsche Bank upgrades the stock from Sell to Hold with a price target of $18.00.
Sarepta Therapeutics (SRPT) — Deutsche Bank Aktiengesellschaft upgrades the stock to Sell ? Hold and raises its price target to $18.00 from $14.00.
Scholar Rock (SRRK) — Raymond James Financial reiterates its Strong-Buy rating.
SEA (SE) — Jefferies Financial Group maintains its Buy rating and lowers its price target to $142.00 from $164.00.
Securitize (SECZ) — Needham & Company LLC maintains its Buy rating and raises its price target to $13.00 from $11.00.
Securitize (SECZ) — Rosenblatt Securities maintains its Buy rating and lowers its price target to $12.00 from $13.00.
Securitize, Inc. (SECZ) — Citigroup upgrades the stock from Neutral to Buy with a price target of $14.00.
Sensei Biotherapeutics (FTH) — Citigroup maintains its Buy rating and raises its price target to $60.00 from $55.00.
Senseonics (SENS) — Raymond James upgrades the stock from Underperform to Market Perform.
Senseonics Holdings, Inc. Common Stock (SENS) — Barclays maintains its Equal Weight rating and raises its price target to $11.00 from $10.00.
Senseonics Holdings, Inc. Common Stock (SENS) — HC Wainwright reiterates its Buy rating with a price target of $14.00.
Senseonics Holdings, Inc. Common Stock (SENS) — Mizuho maintains its Outperform rating and raises its price target to $20.00 from $18.00.
Senseonics Holdings, Inc. Common Stock (SENS) — Stifel Nicolaus maintains its Hold rating and raises its price target to $10.00 from $9.00.
Senseonics Holdings, Inc. Common Stock (SENS) — TD Cowen maintains its Buy rating and raises its price target to $17.00 from $15.00.
Septerna (SEPN) — Stifel Nicolaus maintains its Buy rating and raises its price target to $60.00 from $49.00.
Shake Shack (SHAK) — JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $77.00 from $75.00.
Sharplink Gaming (SBET) — B. Riley Financial maintains its Buy rating and lowers its price target to $11.00 from $14.00.
Shift4 Payments (FOUR) — Mizuho maintains its Outperform rating and raises its price target to $56.00 from $46.00.
Sirius XM (SIRI) — UBS Group sets a price target of $27.00.
Skydance (SKYD) — Citizens Jmp maintains its Market Outperform rating and lowers its price target to $13.00 from $14.00.
Skydance (SKYD) — Wells Fargo & Company maintains its Underweight rating and raises its price target to $8.00 from $7.00.
Skyworks Solutions (SWKS) — JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $77.00 from $65.00.
Somnigroup International (SGI) — KeyCorp maintains its Overweight rating and lowers its price target to $100.00 from $105.00.
Somnigroup International (SGI) — Morgan Stanley maintains its Overweight rating and lowers its price target to $90.00 from $95.00.
Somnigroup International (SGI) — UBS Group maintains its Buy rating and lowers its price target to $87.00 from $102.00.
Southern Copper (SCCO) — UBS upgrades the stock from Sell to Neutral with a price target of $180.00.
Sterling Infrastructure (STRL) — JP Morgan initiates coverage with an Overweight rating with a price target of $585.00.
Sterling Infrastructure (STRL) — JPMorgan Chase & Co. initiates coverage with an Overweight rating with a price target of $585.00.
Sun Communities (SUI) — Robert W. Baird maintains its Neutral rating and lowers its price target to $131.00 from $138.00.
Super Micro Computer (SMCI) — Susquehanna maintains its Negative rating and raises its price target to $18.00 from $15.00.
Surgery Partners (SGRY) — Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $25.00 from $23.50.
Surrozen (SRZN) — Cantor Fitzgerald maintains its Overweight rating and raises its price target to $62.00 from $40.00.
Take-Two Interactive Software (TTWO) — BMO Capital Markets reiterates its Outperform rating.
Take-Two Interactive Software (TTWO) — BTIG Research reiterates its Buy rating with a price target of $262.00.
Take-Two Interactive Software (TTWO) — Jefferies Financial Group reiterates its Buy rating.
Take-Two Interactive Software (TTWO) — Oppenheimer reiterates its Outperform rating.
Take-Two Interactive Software (TTWO) — TD Cowen reiterates its Buy rating.
Take-Two Interactive Software (TTWO) — UBS Group maintains its Buy rating and lowers its price target to $295.00 from $300.00.
Tango Therapeutics (TNGX) — HC Wainwright maintains its Buy rating and lowers its price target to $67.00 from $68.00.
Tango Therapeutics (TNGX) — Jefferies Financial Group reiterates its Buy rating with a price target of $65.00.
Tango Therapeutics (TNGX) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $47.00 from $46.00.
Tango Therapeutics (TNGX) — Wedbush maintains its Outperform rating and lowers its price target to $40.00 from $45.00.
Tapestry (TPR) — Cantor Fitzgerald initiates coverage with an Overweight rating with a price target of $159.00.
Targa Resources (TRGP) — Morgan Stanley maintains its Overweight rating and raises its price target to $362.00 from $359.00.
Targa Resources (TRGP) — Scotiabank maintains its Sector Outperform rating and raises its price target to $325.00 from $319.00.
Telos (TLS) — B. Riley Financial maintains its Buy rating and raises its price target to $11.00 from $9.00.
Telos (TLS) — Needham & Company LLC maintains its Buy rating and raises its price target to $9.00 from $6.00.
Telos (TLS) — Wedbush maintains its Neutral rating and raises its price target to $7.00 from $5.00.
TeraWulf (WULF) — Citigroup maintains its Buy rating and lowers its price target to $24.00 from $31.00.
TeraWulf (WULF) — Jefferies Financial Group maintains its Buy rating and lowers its price target to $14.00 from $15.00.
TeraWulf (WULF) — Morgan Stanley maintains its Overweight rating and lowers its price target to $47.00 from $65.00.
TeraWulf (WULF) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $22.00 from $30.00.
Terreno Realty (TRNO) — BTIG Research reiterates its Buy rating with a price target of $80.00.
TJX (TJX) — Cantor Fitzgerald initiates coverage with a Neutral rating with a price target of $139.00.
TJX Companies (TJX) — UBS Group maintains its Buy rating and lowers its price target to $184.00 from $198.00.
Toast (TOST) — Truist Financial maintains its Buy rating and raises its price target to $40.00 from $38.00.
Trade Desk (TTD) — Citigroup maintains its Sell rating and raises its price target to $12.00 from $11.00.
Trade Desk (TTD) — Guggenheim maintains its Neutral rating and raises its price target to $16.00 from $13.00.
Trade Desk (TTD) — KeyCorp reiterates its Sector Weight rating.
Trade Desk (TTD) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $14.00 from $13.00.
Trade Desk (TTD) — Needham & Company LLC reiterates its Buy rating with a price target of $19.00.
Trade Desk (TTD) — Rosenblatt Securities maintains its Neutral rating and raises its price target to $15.00 from $12.00.
Trade Desk (TTD) — Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $18.00 from $15.00.
Trade Desk (TTD) — Scotiabank maintains its Sector Perform rating and raises its price target to $15.00 from $12.00.
Trade Desk (TTD) — Susquehanna maintains its Neutral rating and raises its price target to $17.00 from $14.00.
Trade Desk (TTD) — Truist Financial maintains its Hold rating and sets a price target of $17.00 from $16.00.
Trade Desk (TTD) — UBS Group maintains its Buy rating and raises its price target to $19.00 from $15.00.
Trade Desk (TTD) — Wedbush reiterates its Neutral rating with a price target of $15.00.
Trex (TREX) — DA Davidson downgrades the stock from Buy to Neutral with a price target of $55.00.
Turning Point Brands (TPB) — Needham & Company LLC maintains its Buy rating and lowers its price target to $95.00 from $125.00.
TWFG (TWFG) — Morgan Stanley maintains its Overweight rating and raises its price target to $31.00 from $30.00.
TWFG (TWFG) — UBS Group maintains its Buy rating and raises its price target to $36.00 from $34.00.
United Dominion Realty Trust (UDR) — UBS Group maintains its Buy rating and raises its price target to $43.00 from $39.00.
United Parks & Resorts (PRKS) — Guggenheim maintains its Buy rating and raises its price target to $56.00 from $54.00.
Uniti Group (UNIT) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $9.00 from $11.00.
Uniti Group (UNIT) — Raymond James Financial reiterates its Strong-Buy rating with a price target of $12.00.
Uniti Group (UNIT) — Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $4.00 from $9.00.
Unum Group (UNM) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $85.00 from $92.00.
USA Rare Earth (USAR) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $30.00 from $40.00.
V2X (VVX) — Citigroup maintains its Neutral rating and raises its price target to $83.00 from $75.00.
Venture Global (VG) — Sanford C. Bernstein reiterates its Market Perform rating with a price target of $14.00.
Veracyte (VCYT) — Piper Sandler maintains its Overweight rating and lowers its price target to $30.00 from $54.00.
Veradermics (MANE) — Citigroup maintains its Buy rating and raises its price target to $175.00 from $160.00.
Vericel (VCEL) — Stephens maintains its Overweight rating and raises its price target to $68.00 from $55.00.
Verisk Analytics (VRSK) — Raymond James Financial reiterates its Strong-Buy rating with a price target of $245.00.
Via Transportation (VIA) — Citigroup reiterates its Market Outperform rating.
Via Transportation (VIA) — Citizens Jmp maintains its Market Outperform rating and raises its price target to $55.00 from $37.00.
Via Transportation (VIA) — Guggenheim maintains its Buy rating and raises its price target to $58.00 from $50.00.
Via Transportation (VIA) — Morgan Stanley maintains its Overweight rating and raises its price target to $48.00 from $33.00.
Via Transportation (VIA) — Wells Fargo & Company maintains its Overweight rating and raises its price target to $50.00 from $32.00.
Viant Technology (DSP) — DA Davidson initiates coverage with a Buy rating.
Viant Technology (DSP) — UBS Group maintains its Buy rating and lowers its price target to $18.00 from $19.00.
Vir Biotechnology (VIR) — Morgan Stanley maintains its Overweight rating and raises its price target to $28.00 from $25.00.
Virtus Investment Partners (VRTS) — Piper Sandler maintains its Overweight rating and raises its price target to $162.00 from $146.00.
Visa (V) — Citigroup maintains its Buy rating and raises its price target to $490.00 from $440.00.
Vistance Networks (VISN) — Northland Capital downgrades the stock from Outperform to Market Perform with a price target of $4.00.
Vistance Networks (VISN) — Northland Securities downgrades the stock to Outperform ? Market Perform with a price target of $4.00.
Vital Farms (VITL) — UBS Group reiterates its Buy rating with a price target of $18.00.
Vivid Seats (SEAT) — Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $4.00 from $9.00.
Voyager Technologies (VOYG) — Citigroup maintains its Buy rating and lowers its price target to $41.00 from $54.00.
Walmart (WMT) — Mizuho maintains its Outperform rating and sets a price target of $135.00 from $125.00.
Welltower (WELL) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $273.00 from $260.00.
Welltower (WELL) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $266.00 from $260.00.
Western Midstream Partners (WES) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $50.00 from $55.00.
WhiteHorse Finance (WHF) — B. Riley Securities upgrades the stock from Neutral to Buy and raises its price target to $9.00 from $8.00.
WhiteHorse Finance (WHF) — JPMorgan Chase & Co. maintains its Underweight rating and raises its price target to $7.50 from $6.50.
Wix.com (WIX) — BofA Securities downgrades the stock from Buy to Underperform and lowers its price target to $68.00 from $75.00.
Wix.com (WIX) — Jefferies Financial Group reiterates its Buy rating with a price target of $85.00.
Wix.com (WIX) — JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $59.00 from $62.00.
Wix.com (WIX) — Wedbush reiterates its Neutral rating.
XPLR Infrastructure (XIFR) — Jefferies Financial Group maintains its Buy rating and lowers its price target to $11.00 from $14.00.
York Space Systems (YSS) — Citigroup maintains its Buy rating and lowers its price target to $10.00 from $13.00.
Zentalis Pharma (ZNTL) — Wedbush upgrades the stock from Neutral to Outperform and raises its price target to $6.00 from $5.00.
Zeta Global (ZETA) — B. Riley Financial maintains its Buy rating and raises its price target to $39.00 from $38.00.
Zeta Global (ZETA) — Citigroup maintains its Buy rating and raises its price target to $38.00 from $35.00.
Zeta Global (ZETA) — KeyCorp reiterates its Overweight rating with a price target of $38.00.
Zeta Global (ZETA) — Needham & Company LLC reiterates its Buy rating.
Zeta Global (ZETA) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $41.00 from $40.00.
Zeta Global (ZETA) — Truist Financial maintains its Buy rating and raises its price target to $40.00 from $38.00.
ZipRecruiter (ZIP) — UBS Group maintains its Neutral rating and raises its price target to $5.00 from $4.50.
Zura Bio (ZURA) — Oppenheimer maintains its Outperform rating and lowers its price target to $5.00.
Zymeworks (ZYME) — HC Wainwright maintains its Buy rating and raises its price target to $56.00 from $55.00.
Zymeworks (ZYME) — TD Cowen maintains its Buy rating and raises its price target to $39.00 from $34.00.
Zymeworks (ZYME) — Truist Financial maintains its Buy rating and raises its price target to $36.00 from $35.00.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Related research
How Trump’s Tariffs Could Shake Up Magna International’s Auto Parts Business
STA Research (Rank#25) Maintained “Hold” Rating on Starbucks, $110 target (SBUX:NSD)
Bank of Canada Looks to Pause rates as Recession Looms
American Analyst Updates: Nov 9th, 2026
American Analyst Updates: Nov 6th, 2026
American Analyst Updates: Nov 5th, 2026
A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.